Judge approves Bayer's $7.25bn Roundup payout, potentially ending 65,000 cancer claims
A St. Louis judge called the deal 'fair, reasonable and adequate', giving the German giant its best shot in nearly a decade at capping the Roundup litigation that has weighed on the company.
By Abdullah Al-Otaibi·· 4 min


